MARKET WIRE NEWS
  1. Home
  2. Stock
  3. SABS
  4. News
SABS
Quote
Short
News
Articles
Message Board

SAB Biotherapeutics Inc. (NASDAQ : SABS ) News

SAB Biotherapeutics Inc. (NASDAQ: SABS) News Releases

SABS News Releases
SABS : NASDAQ
GlobeNewswire
SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director
SABS : NASDAQ
KlickAnalytics
SABS Price Target Alert: $7.00. Issued by UBS
SABS : NASDAQ
GlobeNewswire
SAB BIO to Present at the 44th Annual J.P. Morgan Healthcare Conference
SABS : NASDAQ
GlobeNewswire
First Patient Dosed in SAB BIO's SAFEGUARD Clinical Trial of SAB-142 for the Treatment of Stage 3 T1D
SABS : NASDAQ
GlobeNewswire
SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D
SABS : NASDAQ
GlobeNewswire
SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management
SABS : NASDAQ
SeekingAlpha
SAB Biotherapeutics reports Q3 results
SABS : NASDAQ
GlobeNewswire
SAB BIO Reports Third Quarter Financial Results and Recent Business Highlights
SABS : NASDAQ
US Earnings Reports
Expected US Company Earnings on Wednesday, November 12th, 2025
SABS : NASDAQ
US Earnings Reports
Expected US Company Earnings on Wednesday, November 5th, 2025

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.